What is the current market size and future outlook for the polymerase chain reaction (pcr) technologies market?
The polymerase chain reaction (PCR) technologies market size has grown rapidly in recent years. It will grow from $14.58 billion in 2024 to $16.36 billion in 2025 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to the increased number of genome-based drug development activities, growth in the prevalence of genetic disorders and target diseases, increased use of miniaturized portable instruments, growth in use of biomarker profiling, and growth in demand for personalized medicine.
The polymerase chain reaction (PCR) technologies market size is expected to see rapid growth in the next few years. It will grow to $25.76 billion in 2029 at a compound annual growth rate (CAGR) of 12.0%. The growth in the forecast period can be attributed to a rise in demand for rapid and accurate diagnosis of disease, growing demand for forensics, growing adoption of real-time polymerase chain reaction, the growing demand for rapid and on-site diagnostic testing, rise in infectious disease outbreaks, and demand for companion diagnostics. Major trends in the forecast period include next-generation sequencing (NGS) integration, RNA detection and analysis, single-cell PCR analysis, bioinformatics software and data analysis tools, microfluidic technologies, lab-on-a-chip systems, and point-of-care testing (POCT), artificial intelligence (AI) and data analytics.
Get Your Free Sample of The Global Polymerase Chain Reaction (PCR) Technologies Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15639&type=smp
How have varous drivers impacted the growth of the polymerase chain reaction (pcr) technologies market?
An increasing prevalence of infectious diseases is expected to propel the growth of the PCR technologies market going forward. Infectious diseases refer to illnesses caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungi that can spread directly or indirectly from one person to another. The increasing prevalence of infectious diseases highlights the growing challenges posed by pathogens, potentially due to factors such as globalization, urbanization, antimicrobial resistance, and environmental changes. PCR technologies mitigate the prevalence of infectious diseases by detecting and amplifying specific genetic material of pathogens, aiding in their identification and diagnosis with high sensitivity and accuracy. For instance, in November 2023, according to the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for international public health, 10.6 million cases of tuberculosis (TB) are predicted to occur globally in 2022, affecting 5.8 million men, 3.5 million women, and 1.3 million children. Therefore, the increasing prevalence of infectious diseases is driving the PCR technologies market.
What are the primary segments of the polymerase chain reaction (pcr) technologies market?
The polymerase chain reaction (PCR) technologies market covered in this report is segmented –
1) By Product: Reagents And Consumables, Instruments, Software, Services
2) By Technology: Real-Time Polymerase Chain Reaction, Conventional Polymerase Chain Reaction, Reverse Transcription Polymerase Chain Reaction, Digital Polymerase Chain Reaction, Multiplex Real-Time (RT) Polymerase Chain Reaction, Hot Start Polymerase Chain Reaction, Other Technologies
3) By Application: Gene Expression Analysis, Genetic Sequencing, Genotyping, Nucleic Acid Synthesis, Standard Validation, Point Of Care Diagnostics, Environmental Application, Other Applications
4) By End Users: Hospitals And Diagnostic Centers, Research Laboratories And Academic Institutes, Pharmaceutical And Biotechnology Companies, Other End Users
Subsegments:
1) By Reagents And Consumables: Pcr Master Mixes, Primers And Probes, Dna Or Rna Extraction Kits, Pcr Enzymes, Buffers And Solutions, Pcr Plates, Tubes, And Strips, Nucleotides
2) By Instruments: Pcr Machines (Thermal Cyclers), Real-Time Pcr Systems (Qpcr Systems), Digital Pcr Systems, Automated Pcr Platforms, Gel Electrophoresis Systems, Pcr Workstations
3) By Software: Pcr Data Analysis Software, Real-Time Pcr Software, Digital Pcr Software, Sequence Analysis Software, Multiplex Pcr Software, Laboratory Information Management Systems (Lims) For Pcr
4) By Services: Pcr Testing Services, Custom Pcr Primer Design Services, Pcr Training And Consultation Services, Pcr Sample Analysis Services, Pcr-based Diagnostic Services, Technical Support And Maintenance Services For Pcr Equipment
Order your report now for swift delivery
Which firms are leading the polymerase chain reaction (pcr) technologies market?
Major companies operating in the polymerase chain reaction (PCR) technologies market are F. Hoffmann-La Roche Ltd., Bayer Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson and Company (BD), GE Healthcare Technologies LLC, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc., Ambry Genetics Corporation, Veritas Genetics Inc.
How will industry trends affect the trajectory of the polymerase chain reaction (pcr) technologies market?
Major companies operating in the PCR technologies market are focused on developing advanced technological solutions, such as next-gen quantitative polymerase chain reaction (qPCR) technologies, to improve accuracy, sensitivity, and efficiency in molecular diagnostics. Quantitative polymerase chain reaction (qPCR) technology quantifies specific DNA sequences in samples, offering real-time monitoring and amplification, rendering it invaluable across scientific and medical disciplines. For instance, in November 2023, F. Hoffmann-La Roche AG, a Switzerland-based biotechnology company, launched the LightCycler PRO System, a next-generation qPCR (quantitative polymerase chain reaction) system designed to advance clinical needs in molecular diagnostics and address public health challenges. This system is intended to be the most advanced qPCR technology for both clinical diagnostics and research, offering improved performance and usability while bridging the gap between translational research and in vitro diagnostics. It harnesses gold-standard technology, ensuring quality, precision, and reliability essential for precise patient diagnosis and informed clinical decisions.
Which geographic trends are shaping the polymerase chain reaction (pcr) technologies market, and which region has the highest market share?
North America was the largest region in the PCR technologies market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymerase chain reaction (PCR) technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Polymerase Chain Reaction (PCR) Technologies Market Report 2025 Offer?
The polymerase chain reaction (pcr) technologies market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Polymerase chain reaction (PCR) technologies refer to laboratory techniques used to amplify and analyze DNA sequences. It is a fundamental tool in molecular biology and is widely used in various applications, such as genetic testing, diagnostics, forensics, and research.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15639
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
